Yahoo
OTC Markets OTCPK - Delayed Quote USD

Pro Medicus Limited (PMCUF)

132.14 -4.88 (-3.57%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for PMCUF
  • Previous Close 137.02
  • Open 118.64
  • Bid 131.39 x 10000
  • Ask 144.22 x 30000
  • Day's Range 118.64 - 118.64
  • 52 Week Range 74.52 - 180.00
  • Volume 13
  • Avg. Volume 182
  • Market Cap (intraday) 14.456B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) 76.83
  • EPS (TTM) 1.72
  • Earnings Date Aug 18, 2026
  • Forward Dividend & Yield 0.49 (0.37%)
  • Ex-Dividend Date Sep 8, 2026
  • 1y Target Est --

Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

www.promed.com.au

153

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

PMCUF
8.61%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

PMCUF
26.45%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

PMCUF
161.02%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

PMCUF
243.88%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    101.40%

  • Return on Assets (ttm)

    25.84%

  • Return on Equity (ttm)

    74.97%

  • Revenue (ttm)

    261.69M

  • Net Income Avi to Common (ttm)

    265.34M

  • Diluted EPS (ttm)

    1.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    252.28M

  • Total Debt/Equity (mrq)

    0.49%

  • Levered Free Cash Flow (ttm)

    98.87M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: